Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes?

The objective is to access the role of Roux-en-Y gastric bypass (RYGB) biliopancreatic limb (BPL) length in type 2 diabetes (T2D) outcomes. RYGB is more effective than medical intervention for T2D treatment in obese patients. Despite the scarcity of available data, previous reports suggest that modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nora, Mário, Morais, Tiago, Almeida, Rui, Guimarães, Marta, Monteiro, Mariana P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728768/
https://www.ncbi.nlm.nih.gov/pubmed/29310367
http://dx.doi.org/10.1097/MD.0000000000008859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728768/
https://www.ncbi.nlm.nih.gov/pubmed/29310367
http://dx.doi.org/10.1097/MD.0000000000008859

Ejemplares similares